Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor-specific T-cell immunity: ready for prime time?

P D Greenberg, S R Riddell

    Journal of the National Cancer Institute
    |July 15, 1992
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion.

    Nature communications·2024
    Same author

    Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.

    Nature communications·2018
    Same author

    Fully human CD19-specific chimeric antigen receptors for T-cell therapy.

    Leukemia·2017
    Same author

    CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignancies.

    Clinical pharmacology and therapeutics·2016
    Same author

    Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo.

    Leukemia·2015
    Same author

    HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype.

    Tissue antigens·2012